A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

Looking at options history for Moderna MRNA we detected 21 trades. If we consider the specifics of each trade, it is accurate ...

A single COVID-19 mRNA vaccine dose provided similar protection to that conferred by a 2-dose series among immunocompetent ...

The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack ...

WA Premier Roger Cook has called on Port Hedland councillor Adrian McRae to quit after quoting a Nazi and attacking Western ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Experts hope the Moderna jab could stop people developing the vomiting and diarrhoea bug, which is linked to around 12,000 ...

Revaccination at 12 months with the investigational respiratory syncytial virus (RSV) vaccine mRNA-1345 is well tolerated and supported for eligible older adults, according to study results presented ...

It is hoped a study will show the jab is effective against the highly infectious disease which puts the NHS under "huge ...